Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand.
Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Chawansuntati K, et al. Among authors: wipasa j. Vaccine X. 2024 Mar 16;18:100475. doi: 10.1016/j.jvacx.2024.100475. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38549951 Free PMC article.
Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand.
Hongjaisee S, Chawansuntati K, Sripan P, Rattanathammethee K, Sakkhachornphop S, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Hongjaisee S, et al. Among authors: wipasa j. Vaccine X. 2023 Aug;14:100305. doi: 10.1016/j.jvacx.2023.100305. Epub 2023 Apr 20. Vaccine X. 2023. PMID: 37155476 Free PMC article.
Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations.
Sudjaritruk T, Mueangmo O, Saheng J, Winichakoon P, Salee P, Wongjak W, Chaito T, Praparattanapan J, Nuket K, Solai N, Wipasa J, Chawansuntati K, Chaiwarith R. Sudjaritruk T, et al. Among authors: wipasa j. Vaccines (Basel). 2023 Mar 1;11(3):564. doi: 10.3390/vaccines11030564. Vaccines (Basel). 2023. PMID: 36992147 Free PMC article.
A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac-ChAdOx1.
Pongsatha S, Tongsong T, Wipasa J, Sakkhachornphop S, Hongjaisee S, Chawansuntati K. Pongsatha S, et al. Among authors: wipasa j. Hum Vaccin Immunother. 2023 Dec 31;19(1):2196912. doi: 10.1080/21645515.2023.2196912. Epub 2023 Apr 14. Hum Vaccin Immunother. 2023. PMID: 37057690 Free PMC article.
Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine.
Chaiwarith R, Winichakoon P, Salee P, Sudjaritruk T, Wipasa J, Chawansuntati K, Yasri S, Thongwitokomarn H, Krasaewes K, Ruangsirinusorn S, Praparattanapan J, Solai N, Nuket K, Boonmee D, Chaichana O, Mueangmo O, Saheng J, Wongjak W. Chaiwarith R, et al. Among authors: wipasa j. Sci Rep. 2023 Nov 13;13(1):19736. doi: 10.1038/s41598-023-45735-7. Sci Rep. 2023. PMID: 37957189 Free PMC article.
45 results